Natco Sorafenib Tosylate Tablets
| Brand Name | Natco |
|---|---|
| Composition (Generic / INN) | Sorafenib Tosylate |
| Packaging Size | 120 Tablets |
| Packaging Type | Bottle |
| Dosage Form | Tablet |
| Manufacturer | Natco |
| Prescription / Non-Prescription | Prescription |
| Usage / Indication | Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent. |
Gravity Global Export supplies Natco Sorafenib Tosylate Tablets for wholesale pharmaceutical distribution. Each bottle contains 120 tablets of Sorafenib Tosylate, an antineoplastic agent used in the management of advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and differentiated thyroid carcinoma that has recurred or metastasized.
Product Details
- Brand: Natco
- Composition: Sorafenib Tosylate
- Form: Tablet
- Pack Size: 120 Tablets per Bottle
- Pack Type: Bottle
- Prescription: Prescription-only medicine
Export Supply
We source directly from Natco and support licensed distributors, hospitals, pharmacies, and importers with reliable B2B supply. Product handling and documentation are managed in accordance with standard export protocols for oncology medicines.
Contact Gravity Global Export today to request a quotation, confirm availability, and discuss your wholesale requirements.
Interested in this product?
Tell us your quantity and destination — our export team replies with a competitive quotation.